VIRATHERAPEUTICS

ViraTherapeutics is a distinct unit of the Discovery Research organization of the Boehringer Ingelheim group of companies. It was previously formed as a spin-off of the Medical University of Innsbruck in April 2013... ViraTherapeutics specializes in the development of highly potent anti-cancer therapeutics based on oncolytic (cancer-destroying) viruses. The proprietary oncolytic virus, VSV-GP, efficiently destroys cancer cells, while leaving normal tissues unharmed... ViraTherapeutics develops a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Our patent protected virus is designed to be sa...

Also known as: The ViraTherapeutics GmbH, ViraTherapeutics GmbH

VAT numbers: ATU67990855

Primary location: Rum Austria